Literature DB >> 10223410

TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies.

E K Mathey1, J D Pollard, P J Armati.   

Abstract

Proinflammatory cytokines contribute to the regulation of the disease process in inflammatory neuropathies. Cellular localisation of cytokine expression in CIDP nerve biopsies should provide further insight into the pathogenic mechanisms of the disease and the individual cells involved. In this study in situ hybridisation was used to determine the exact localisation and identity of cells that express TNF alpha, IFN gamma and IL-2 mRNA within the CIDP nerve. Paraffin embedded and frozen sural nerve biopsies from three acute phase CIDP patients were used for the study. Sections of these samples were probed with digoxigenin labelled oligoprobes for TNF alpha, IFN gamma and IL-2. The results demonstrate localisation of cytokine expression to the inner rim of the perineurium, epineurial and endoneurial blood vessels and infiltrating inflammatory cells. In addition strong staining for TNF alpha. mRNA was widespread in the endoneurium in areas consistent with/suggestive of Schwann cells. Expression of cytokines in the perineurium and endoneurial blood vessels may have pertinent implications with respect to the breakdown of the blood nerve barrier associated with CIDP. In the very least the potential for an immunomodulatory role may be ascribed to these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223410     DOI: 10.1016/s0022-510x(99)00009-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  Chronic inflammatory demyelinative polyneuropathy.

Authors:  Gérard Said
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

2.  Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy.

Authors:  Hye-Jung Kim; Cha-Gyun Jung; Mark A Jensen; Danuta Dukala; Betty Soliven
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Chaoling Dong; Kelsey M Greathouse; Rebecca L Beacham; Steven P Palladino; E Scott Helton; Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2017-02-16       Impact factor: 5.330

Review 4.  Molecularly targeted therapies for dysimmune neuropathies.

Authors:  Andreas A Argyriou
Journal:  Mol Med       Date:  2009-05-05       Impact factor: 6.354

5.  Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies.

Authors:  Nurcan Üçeyler; Nadja Riediger; Waldemar Kafke; Claudia Sommer
Journal:  J Neurol       Date:  2014-11-05       Impact factor: 4.849

Review 6.  Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.

Authors:  Lisha Tang; Qianyi Huang; Zhen Qin; Xiangqi Tang
Journal:  J Neurol       Date:  2020-04-07       Impact factor: 4.849

Review 7.  Status of immune mediators in painful neuropathies.

Authors:  Nurcan Uçeyler; Claudia Sommer
Journal:  Curr Pain Headache Rep       Date:  2008-06

8.  Frataxin deficiency induces Schwann cell inflammation and death.

Authors:  Chunye Lu; Robert Schoenfeld; Yuxi Shan; Hsing-Jo Tsai; Bruce Hammock; Gino Cortopassi
Journal:  Biochim Biophys Acta       Date:  2009-08-10

Review 9.  Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.

Authors:  Eroboghene E Ubogu
Journal:  Acta Neuropathol       Date:  2015-08-12       Impact factor: 17.088

Review 10.  Biology of the human blood-nerve barrier in health and disease.

Authors:  Eroboghene E Ubogu
Journal:  Exp Neurol       Date:  2020-03-03       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.